SCHEMBL25645642

SCHEMBL25645642

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc6sc7ccccc7c56)c4)nc(-c4ccc5c(c4)oc4ccccc45)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.36
ALOX5 P09917 2/20 0.35
HCRTR1 O43613 1/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
BRDT Q58F21 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
AHR P35869 1/20 0.33
LIMK1 P53667 1/20 0.33
F9 P00740 1/20 0.33
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25645671 0.99 HCRTR1 (0.36) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL25645666 0.98 HCRTR1 (0.37) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL25645660 0.97 HCRTR1 (0.36) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL25458878 0.97 PRKDC (0.36) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL24097528 0.97 PRKDC (0.36) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL25645656 0.97 F9 (0.36) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL25645611 0.97 F9 (0.36) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL22760460 0.97 PRKDC (0.37) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL25646032 0.96 HCRTR1 (0.33) PRKDCALOX5HCRTR1MMP12MMP13
SCHEMBL23913450 0.96 HCRTR1 (0.37) PRKDCALOX5HCRTR1MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165145-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, CYP1A1, CYP1B1 PRKDC 4643/4885ALOX5 519/4885HCRTR1 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.